US 11,987,831 B2
Processes for producing a fermentation product
Randall Deinhammer, Wake Forest, NC (US); Joyce Craig, Pittsboro, NC (US); Suzanne Clark, Youngsville, NC (US); John Matthews, Louisburg, NC (US); Anne Glud Hjulmand, Bagsvaerd (DK); Chee-Leong Soong, Raleigh, NC (US); and Zhengfang Kang, Raleigh, NC (US)
Assigned to NOVOZYMES A/S, Bagsvaerd (DK)
Filed by NOVOZYMES A/S, Bagsvaerd (DK)
Filed on Apr. 13, 2021, as Appl. No. 17/229,246.
Application 16/702,746 is a division of application No. 15/961,269, filed on Apr. 24, 2018, granted, now 10,526,620, issued on Jan. 7, 2020.
Application 15/961,269 is a division of application No. 14/648,477, granted, now 10,227,613, issued on Mar. 12, 2019, previously published as PCT/US2013/071982, filed on Nov. 26, 2013.
Application 17/229,246 is a continuation of application No. 16/702,746, filed on Dec. 4, 2019, abandoned.
Application 14/648,477 is a continuation in part of application No. 14/388,595, granted, now 9,856,498, issued on Jan. 2, 2018, previously published as PCT/US2013/034337, filed on Mar. 28, 2013.
Claims priority of provisional application 61/731,806, filed on Nov. 30, 2012.
Claims priority of provisional application 61/617,799, filed on Mar. 30, 2012.
Prior Publication US 2021/0230644 A1, Jul. 29, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. C12N 9/62 (2006.01); C12N 9/26 (2006.01); C12N 9/28 (2006.01); C12N 9/38 (2006.01); C12N 9/44 (2006.01); C12N 9/52 (2006.01); C12N 9/58 (2006.01); C12P 7/06 (2006.01); C12P 7/08 (2006.01); C12P 7/14 (2006.01); C12P 19/14 (2006.01); C13K 1/06 (2006.01)
CPC C12P 7/14 (2013.01) [C12N 9/2414 (2013.01); C12N 9/2417 (2013.01); C12N 9/2457 (2013.01); C12N 9/52 (2013.01); C12N 9/58 (2013.01); C12N 9/62 (2013.01); C12P 7/06 (2013.01); C12P 7/08 (2013.01); C12P 19/14 (2013.01); C13K 1/06 (2013.01); C12P 2201/00 (2013.01); C12P 2203/00 (2013.01); Y02E 50/10 (2013.01)] 14 Claims
 
1. A cellulolytic composition comprising:
(a) a beta-glucosidase having an amino acid sequence that is at least 85% identical to the amino acid sequence of SEQ ID NO: 22 and having the substitutions F100D, S283G, N456E and F512Y; and
(b) a cellobiohydrolase having an amino acid sequence that is at least 85% identical to the amino acid sequence of SEQ ID NO: 24; and
(c) an endoglucanase.